Home
>
National Drug Code (NDC)
>
LOVASTATIN
LOVASTATIN - 54458-916-10 - (LOVASTATIN)
Drug Information of LOVASTATIN
| Product NDC: | 54458-916 |
| Proprietary Name: | LOVASTATIN |
| Non Proprietary Name: | LOVASTATIN |
| Active Ingredient(s): | 10 mg/1 & nbsp; LOVASTATIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LOVASTATIN
| Product NDC: | 54458-916 |
| Labeler Name: | International Labs, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075551 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080327 |
Package Information of LOVASTATIN
| Package NDC: | 54458-916-10 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (54458-916-10) |
NDC Information of LOVASTATIN
| NDC Code | 54458-916-10 |
| Proprietary Name | LOVASTATIN |
| Package Description | 30 TABLET in 1 BLISTER PACK (54458-916-10) |
| Product NDC | 54458-916 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LOVASTATIN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080327 |
| Marketing Category Name | ANDA |
| Labeler Name | International Labs, Inc. |
| Substance Name | LOVASTATIN |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
